Meredith Pelster, Meredith Pelster, MD, MSCI

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    SQZ Biotechnologies
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tachyon Therapeutics
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Takeda
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    TORL Biotherapeutics
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    TransThera Sciences
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ZielBio
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    1200 Pharma
    Topic:
    Paid to Institution for work as PI
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Arcus Biosciences
    Topic:
    Paid to institution for consulting work
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Topic:
    Paid to institution for consulting work
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Curio Science
    Topic:
    Paid to institution for consulting work
    Date added:
    05/13/2025
    Date updated:
    05/13/2025

Pages

Return to 2025 Seattle Cellular Therapy Summit: Bringing Cellular Therapies to Every Patient, Everywhere